Bridgehead International Ltd announced today that it has entered into an agreement with Jouhou Koukai Services LLC, of Tokyo, Japan, to provide certain joint services to clients in the pharmaceutical, medical device and diagnostics sectors.
Bridgehead International Ltd announced today that it has entered into an agreement with RXB Management Consulting, of Shanghai, China to provide certain joint services to clients in the pharmaceutical, medical device and diagnostics sectors.
The pharmaceutial and medical device consulting services of Bridgehead International are featured in the quarterly bulletin published by the British Embassy in Tokyo, Japan.
Cervical cancer screening using both an FDA-approved HPV DNA test plus a Pap test (co-testing) is supported by major clinical practice guidelines, but some clinicians may have concerns about implementing this process in their practices. Will patients still come back for their annual examination if they donâ??t need to be tested yearly? Will reimbursement be a problem? Bridgehead and Dr Karen Ilka report on the findings of a recent survey.
Personalised Medicine - Bridgehead International Enhances its Services. Natalie A. Cummins, of DHC Consulting will be joining Bridgehead International as an Affiliate. Bridgehead's services will be expanded to offer payer expertise in the area of personalized medicine, including marketplace assessments, product coverage determinations and reimbursement strategy. In addition, the affiliation strengthens Bridgehead's existing expertise in the diagnostic market access space, based on Ms. Cumminsâ?? experience at Quest Diagnostics, working with converging technologies, and conducting strategic planning for diagnostic companies.
